The role of biomarkers in soft tissue sarcoma treatment and research
Dr. Van Tine Discusses Identifying Biomarkers in SarcomasПодробнее
Potential Role of Immunotherapy in the Treatment of Patients With SarcomaПодробнее
Tumor Mutation Burden: Challenges and opportunitiesПодробнее
Schildhaus HTP UK Biomarkers 2021 PresentationПодробнее
WEBINAR BIOMARKERS IN SARCOMA (15 April 2021)Подробнее
Advances in Therapy for Sarcomas & GISTПодробнее
Predictive biomarkers of response to immunotherapy in soft tissue sarcomaПодробнее
Biomarkers and Pathology for Sarcoma Speaker: Dr. Alaa SalemПодробнее
Efficacy and Biomarker Results for Pembrolizumab in Soft Tissue and Bone SarcomasПодробнее
Diagnostic Testing Procedure for Soft Tissue SarcomaПодробнее
2021 West Oncology APP | Update on SarcomaПодробнее
The Role of Trabectedin in Sarcoma SubtypesПодробнее
Dr. Randall of Tumor Sequencing Research in SarcomasПодробнее
Dr. Jonathan Trent on Pembrolizumab in Advanced SarcomasПодробнее
The role of biomarkers in guiding treatment for early-stage breast cancerПодробнее
The Role of Olaratumab in SarcomaПодробнее
Role of Research in Radiation Medicine for Extremity Soft Tissue Sarcoma - Colleen DickieПодробнее
Addressing the lack of sarcoma biomarkersПодробнее
Dr. Roman Groisberg discusses Sarcoma via The OncLiveOnAir PodcastПодробнее
Chemotherapy Sensitivity in Soft Tissue SarcomaПодробнее
